HCC Member

G. Mike Makrigiorgos, PhD

Dana-Farber Cancer Institute

Academic Titles
Professor, Radiation Oncology, Harvard Medical School
Research Program Affiliation
Member, Cancer Genetics and Epigenetics
Research Abstract

* Development of DNA technologies for assessing the impact of rare mutations in cancer management

* Development and detection of patient specific biomarkers for cancer prognosis and individual response to therapy. Detection of rare mutations in blood and other bodily fluids via liquid biopsy

* Development of nano-technology-based approaches to improving the therapeutic ratio in radiation therapy

* Radiation dosimetry and dosimetry at the cellular level